INVESTOR & MEDIA

As we are dedicated to the development of life science and technology,
we contribute to humanity by spreading good will with a sense of mission.

INVESTOR & MEDIA

As we are dedicated to the development of life science and technology,
we contribute to humanity by spreading good will with a sense of mission.

일리미스테라퓨틱스 2024년도 병역지정업체 선정

  • 등록일

    2024-01-09

  • 조회수

    131


 

혁신적 융합단백질 플랫폼 기술인 GAIA를 기반으로 퇴행성 뇌 질환 및 면역질환 치료제를 개발하는 일리미스테라퓨틱스가 2024년 병역지정업체(연구기관)로 선정되었다.  

 

‘전문연구요원제도’는 이공계 석박사 학위를 취득한 고급 인력에게 학문과 과학기술의 지속적인 성장과 함께 국가 산업의 육성·발전에 기여할 수 있도록 3년 간 병무청장이 선정한 지정업체에 복무함으로서 병역 의무를 이행하는 제도이다.

 

일리미스는 전문연구요원 채용을 통하여 GAIA 플랫폼 기술을 통한 신약개발 가속화를 위하여 박차를 가할 계획이다. 



목록으로